Objective: The present study aims to explore the association between phthalate exposure and the risk of gestational diabetes mellitus (GDM).
Materials and Methods: A total of 11 plasticizer metabolites were measured in patient morning urine using high-performance liquid chromatography. Furthermore, fasting blood glucose and fasting insulin were detected in first-trimester blood samples. The chemical concentration was described using the median, the metabolite concentration difference between the GDM and control groups was compared using the bootstrap method, and the correlations of the fasting blood glucose, fasting insulin, insulin resistance index, and phthalic acid ester (PAE) metabolites were analyzed using Spearman correlation analysis. The multivariate logistic regression model and predictive probability map were performed to help assess the linearity and nature of any dose–response relationship.
Results: Of the 224 women recruited for the present study, 200 met the inclusion criteria. Their measured outcomes and biomonitoring data were examined for the presence of chemicals. The results showed that the patients in the GDM group had higher mono-(2-ethylhexyl) phthalate (MEHP) and methylerythritol cyclophosphane concentrations in their bodies than the patients in the control group. Statistically significant MEHP–GDM associations were also observed (P < 0.001). The GDM and MEHP dose–response relationships were different among pregnant women aged < 35 years and those aged > 35 years (P < 0.001). Furthermore, gestational age > 28 weeks exhibited similar changes to those aged ≤ 28 weeks (P = 0.059).
Conclusion: The findings of the present study add to the growing body of evidence supporting phthalate exposure as a GDM risk factor.
Keywords: phthalate exposure, gestational diabetes, dose-response relationships, association